MTN-033 is launched.

MTN is excited to announce the launch of our next rectal microbicide study, MTN-033. The study will help determine the distribution of dapivirine gel in rectal tissue. Congratulations to the MTN-033 study team and the University of Pittsburgh Clinical Research Site for making this study a reality!